Sandra Gunselman is a leader in the regulated medical device industry, with a background in cellular and molecular biology. She holds a Ph.D. in Cellular & Molecular Biology from Colorado State University and a B.S. in Biology from David Lipscomb University. With over two decades of experience in the field, Sandra has demonstrated her skills in cost management, efficiency improvement, waste elimination, and building high-performance teams.

Sandra's experience includes serving as the CEO/Founder of Mobility Health, Vice President Diagnostics at BRIDGenomics, Executive Director Advanced Diagnostics Laboratories at National Jewish Health, Vice President Laboratory Operations at Assurex Health, Vice President Clinical Operations at Transgenomic, Director of Clinical Operations at Transgenomic, Senior Regulatory Affairs Scientist at Transgenomic, Laboratory Director at Kailos Genetics, Senior Research Scientist at Transgenomic, Medical Science Liaison at NuTechnologies, Research Assistant Professor at University of Nebraska Medical Center, Postdoctoral Fellow at Eppley Cancer Research Center, Senior Fellow of Immunology at University of Washington, Scientist II at US Army, Senior Scientist/Laboratory Supervisor at Pacific Northwest Research Foundation, Assistant EditorAquatic Toxicology at Elsevier B.V, Research Assistant at University of Alabama, and Research Assistant at Vanderbilt University.

Throughout her career, Sandra has developed expertise in Lean Operations, Project Management, CLIA/CAP Operational Excellence, GMP, and GLP. She has also implemented efficient LIMS and Cycle Revenue Billing systems, reducing average TAT from 11 to 5 weeks in a 12 month period while reducing cost. Additionally, Sandra has a strong technical background and excels in risk assessment analysis.

Sandra is an excellent team builder and relationship builder with a passion for advancing the medical device industry.